Insmed Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€20.00
Target price
04.08.24
€37.17
Performance (%)
237.50%
End price
05.08.24
€67.50
Summary
This prediction ended on 05.08.24 with a price of €67.50. The BUY prediction by Morgan_Stanley for Insmed Inc. saw massive gains of 237.50%. Morgan_Stanley has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Insmed Inc. | -3.400% | -3.400% | 2.611% | 456.884% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% | 64.713% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% | 88.244% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% | 79.311% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% | 69.603% |
Comments by Morgan_Stanley for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $41.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten